Why It's Moving

Why It's Moving Recent News

IonQ Stock Pops On Q1 Earnings: Revenue Beat, EPS Beat, Stronger Guidance On Increased Visibility And More
IonQ said first-quarter revenue increased 77% year-over-year to $7.582 million, which beat the consensus estimate of $7.075 million, according to Benzinga Pro. The quantum computing company reported a quarterly loss of 19 cents per share, which beat analyst estimates for a loss of 24 cents per share.
Beyond Meat Q1 Earnings: Revenue Beat, EPS Miss, Working To Make 2024 A Pivotal Year And More
Beyond Meat said first-quarter revenue decreased 18% year-over-year to $75.603 million, which beat consensus estimates of $75.241 million, per Benzinga Pro. The plant-based meat company reported a first-quarter adjusted loss of 72 cents per share, which missed estimates for a loss of 67 cents per share.
Instacart Reports Better-Than-Expected Q1 Results Driven By Large Order Numbers
Instacart reported quarterly earnings of 43 cents per share which beat the analyst consensus estimate of losses of 2 cents per share. Quarterly sales came in at $820 million which beat the analyst consensus estimate of $793.44 million by 3.35%.
Chipmaker Arm Holdings Reports Better-Than-Expected Q4 Results: Record Royalty Revenue, Strong License Revenue
Arm Holdings reported quarterly earnings of 36 cents per share which beat the analyst consensus estimate of 30 cents by 20%. Quarterly sales clocked in at $928 million, beating the analyst consensus estimate of $875.59 million by 5.99%.
Airbnb Q1 Earnings: Revenue Beat, EPS Beat, Gross Booking Value Up 12% And More
Airbnb's first-quarter revenue increased 18% year-over-year to $2.14 billion, which beat the consensus estimate of $2.06 billion. Airbnb reported quarterly earnings of 41 cents per share, which beat analyst estimates of 22 cents per share.
Buy Definitive Healthcare Stock On Weakness, Analyst Says As Revised Outlook Appears Achievable
Definitive Healthcare reports Q1 adjusted EPS of $0.08, sales at $63.48M, and adjusted EBITDA of $20 million. Q2 revenue guidance: $62–$63.5 million. FY 2024 revenue outlook: $255–$261 million.
Orthopedic Devices Maker Treace Medical Concepts' Gloomy Forecast Cast Concerns Over Long-Term Viability
Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to expanded surgeon base and product mix shift. FY24 sales guidance adjusted to $201M-$211M. Analysts downgrade, citing competitive challenges.
Toast Stock Soars On Strong Q1 Earnings, Optimistic Growth Prospects
Toast witnessed a remarkable surge of nearly 14% in its share price Wednesday following the release of its first-quarter 2024 financial results.
Why Is New York Times Stock Trading Higher On Wednesday?
New York Times' digital subscribers hit 9.91 million, growing by 210K in Q1. Sales reached $594M, up 5.9% Y/Y. Digital ARPU rose to $9.21. CEO Meredith Kopit Levien emphasizes a strong start in 2024. Guidance predicts subscription revenues up by 6%-8% in Q2.
Upstart Nearing Inflection Point? 2 Analysts Examine Opportunities And Challenges Post-Q1 Earnings
Upstart reports Q1 revenue beat but issues lower Q2 guidance; analysts assess potential inflection point amid earnings season.
Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results
Globus Medical reported quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 57 cents by 26.32% and represents a 35.85% increase over earnings from the same period last year. Quarterly sales came in at $606.67 million which beat the analyst consensus estimate by 3.33% and is a 119.26% increase in sales year-over-year.
Elanco Animal Health's Q1 Earnings Show Improved Base Business, Analyst Highlights Slightly Delayed But Encouraging Pipeline
Elanco Animal Health (NYSE: ELAN) reports Q1 results: adjusted EPS $0.34 (-26% Y/Y), sales $1.21B (-4% Y/Y). 2024 guidance: EPS $0.88-$0.96, revenue $4.46-$4.52 billion.
Coupang Shares Fall After Mixed Q1 Results: Here's Why
Coupang reported quarterly earnings of 5 cents per share which missed the analyst consensus estimate of 6 cents per share, unchanged from the same period last year. Quarterly sales clocked in at $7.11 billion which beat the analyst consensus estimate of $6.91 billion and represents a 22.66% increase over sales of $5.8 billion from the same period last year.
What's Going On With Ingredion Shares After Q1 Results?
Ingredion shares edge up despite $51M charges from South Korean business sale, as Q1 earnings beat but revenues miss expectations.
What's Going On With United Parks & Resorts Shares Wednesday?
United Parks & Resorts reported quarterly earnings per share of 17 cents loss, which beats the analyst consensus of 27 cents loss.
Generics Player Teva Pharmaceutical Aces Late-Stage Schizophrenia Drug Study, Stock Shoots Higher
Results from the Phase 3 SOLARIS trial of TEV-‘749 for schizophrenia treatment. SteadyTeq technology ensures controlled olanzapine release. Clinically meaningful improvements in PANSS scores observed across dosing groups.
Why Match Group Stock Is Down 6% Wednesday
Match Group reported earnings on Tuesday after the market close that included GAAP EPS of 44 cents, beating analysts estimates of 41 cents. Match Group also reported sales of $859.658 million, beating analyst estimates of $855.511 million. The company's sales results were up 9.21% from the same period last year.
What's Going On With EV-Maker Mullen Automotive's Stock?
Mullen announced on Monday the addition of a commercial dealer, National Auto Fleet Group, which will offer Mullen's full line of all-electric commercial vehicles in two California locations. Mullen said on Tuesday its subsidiary, Bollinger Motors, and Amerit Fleet Solutions have entered into an agreement for Amerit to provide mobile service and maintenance to Bollinger's commercial fleet customers.
What's Going On With AMC Entertainment Stock Wednesday?
AMC is set to report financial results for the first-quarter after the market close. Analysts are anticipating a loss of 79 cents per share and revenue of $871.002 million, according to estimates from Benzinga Pro.
Why Tivic Health Shares Are Up Today
Tivic Health said it has confirmed the effectiveness of its patent-pending non-invasive cervical vagus nerve stimulation (ncVNS) approach, which induces responses in the autonomic, cardiac, and central nervous systems and can be expected to have clinical utility in several major disease areas.
What's Going On With Performance Food Group Shares Wednesday?
Performance Food Group reported third-quarter earnings miss reflecting difficult operating environment in the fiscal quarter.
What's Going On With Mining Giant BHP Shares Today?
BHP's subsidiary signed Exploration Alliance Agreement with Ivanhoe Electric to explore for copper and other minerals in the US, with a mutual goal of finding new sources for the growing demand. BHP will provide $15M initial funding, with potential for more on a 50/50 basis.
Intel Eyes Q2 Revenue Below Guidance Midpoint, Hit By US Ban On Huawei: Details
U.S. chip export restrictions slightly impact Intel's forecast. The move signals broader market unease over semiconductor supply chains and escalating tensions with Huawei.